Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:rivastigmine
|
| gptkbp:approvedBy |
2007
|
| gptkbp:ATCCode |
gptkb:N06DA03
|
| gptkbp:contraindication |
hypersensitivity to rivastigmine
|
| gptkbp:form |
transdermal patch
13.3 mg/24h 4.6 mg/24h 9.5 mg/24h |
| gptkbp:frequency |
once daily
|
| gptkbp:genericAvailable |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Exelon Patch
|
| gptkbp:launchSite |
chest
upper arm upper back lower back |
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
gptkb:acetylcholinesterase_inhibitor
butyrylcholinesterase inhibitor |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
transdermal
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea loss of appetite skin irritation |
| gptkbp:storage |
store at room temperature
|
| gptkbp:usedFor |
gptkb:Alzheimer's_disease
gptkb:Parkinson's_disease_dementia |
| gptkbp:bfsParent |
gptkb:rivastigmine
|
| gptkbp:bfsLayer |
8
|